ArticleClinical ophthalmology (Auckland, N.Z.)2017

Evaluation of contrast sensitivity and other visual function outcomes in neovascular age-related macular degeneration patients after treatment switch to aflibercept from ranibizumab.

Donald R Nixon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.